Short-term evaluation of motor and sensory nerve conduction parameters in COVID-19-associated peripheral neuropathy patients

The Egyptian Journal of Bronchology

Table 1 Demographic data of the COVID-19 patients with peripheral neuropathy and control group (n = 40)

	COVID-19 group N = 20	Control group N = 20	P value
Gender
Male	17 (85%)	16 (80%)	0.50
Female	3 (15%)	4 (20%)	0.50
Age (years)
Mean ± SD	45.05 ± 11.05	42.35 ± 11.05	0.745
Range	(21–68)	(20–59)	0.745
Smoking
Smoker	8 (40%)	9 (45%)	0.465
Non-smoker	11 (55%)	8 (40%)
X smoker	1 (5%)	3 (15%)
Education
Literate	15 (75%)	17 (85%)	0.347
Illiterate	5 (25%)	3 (15%)	0.347
Residence
Urban	13 (65%)	16 (80%)	0.480
Rural	7 (35%)	4 (20%)	0.480
The onset of neurological symptoms (Range)	11.95 ± 5.90 (4–24)	–-

Data expressed as frequency (percentage) and mean (SD). P value was significant if < 0.05